Ditiatkov A E, Radzevich A E, Tikhonov V A, Gal' I G
Probl Tuberk. 1999(2):31-2.
A total of 108 patients with heart failure-complicated disseminated pulmonary tuberculosis were followed up. Fifty eight patients received combined therapy including the angiotensin-converting enzyme inhibitor ramipril in a daily dose of 0.25-0.50 mg for 1.5-2 months. Fifty ramipril-untreated patients comprised a control group. Examinations revealed the benefits of the agent in decompensatory chronic cor pulmonale as improved right ventricular systolic and diastolic functions and health in the patients.
共对108例心力衰竭合并播散性肺结核患者进行了随访。58例患者接受了联合治疗，其中包括每日剂量为0.25 - 0.50毫克的血管紧张素转换酶抑制剂雷米普利，疗程为1.5 - 2个月。50例未接受雷米普利治疗的患者组成对照组。检查发现该药物对失代偿性慢性肺心病有益，可改善患者右心室的收缩和舒张功能以及健康状况。
